Haynes and Boone, LLP represented Alliqua BioMedical, Inc. in a $29 million asset purchase agreement with Celularity, Inc. The agreement, which is subject to stockholder approval,…
Alliqua BioMedical’s $29 million asset purchase agreement with Celularity, Inc.
